What is ENGNW's relative strength rating?

Relative strength percentiles for ENGNW are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.

What sector is ENGNW in?

ENGNW is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is ENGNW in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). ENGNW benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is ENGNW?

Volatility metrics for ENGNW — average daily range (ADR%), average true range (ATR%), and beta — are not available for the current snapshot. These indicators update daily with each pipeline run.

Does ENGNW have a seasonal pattern?

TickerStance computes ENGNW's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ENGNW has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did ENGNW last report earnings?

No SEC EDGAR filings are linked to ENGNW in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Free

Power rating ↑RS percentile →

One point among 5,323 · As of Monday, August 24, 2026, posted ~17:00 ET

ENGNW

ENGNW is not confirmed as a leader. 3m RS is unavailable, Market Stance is 47.8

enGene Therapeutics Inc. Warrants (ENGNW) — Stance & relative strength

Healthcare · Pharmaceutical Products

$0.30▼ -31.38% todayUSD · close

▼ Stance 48 · Neutral

ENGNW$0.30▼ -31.38%

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, enGene Therapeutics Inc. Warrants (ENGNW) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month—pctile

6 month—pctile

1 year—pctile

Classic—IBD pctile

LDR—leadership

0 of 5 lenses lit · avg RS pctile —

!ADR%—!A/D—!RVOL—!$ Vol—

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

—

LDR

—

StageWeinstein stage analysis

—

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D ratingaccumulation / distribution

—

RVOL todayvs 50d avg

—

U/D ratiolast 50 sessions

—

Breakout volbreakout day vs 50d avg

—

50d avg $ volumeliquidity proxy

—

Risk profile

How much does it move?

Daily range, ATR, beta, and the math for a 1-ADR stop.

ADR% (20d)avg daily range

—

ATR(14)14-day EMA

—

ATR%ATR as % of close

—

Beta vs SPY90d rolling

—

1-ADR stoprisk from close $0.30

—

Fundamentals · ENGNW

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials73

Materials64

Industrials55

Real Estate45

Consumer Staples36

RS pctileLagLead

Public attention · ENGNW

Is the crowd watching?

No attention data for this ticker yet — it joins the daily scan once a baseline builds.

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2836

Floatn/a

Shares outn/a

Market capn/a

FAQ

Frequently asked questions

What is ENGNW's relative strength rating?: Relative strength percentiles for ENGNW are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.
What sector is ENGNW in?: ENGNW is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is ENGNW in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). ENGNW benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is ENGNW?: Volatility metrics for ENGNW — average daily range (ADR%), average true range (ATR%), and beta — are not available for the current snapshot. These indicators update daily with each pipeline run.
Does ENGNW have a seasonal pattern?: TickerStance computes ENGNW's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ENGNW has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did ENGNW last report earnings?: No SEC EDGAR filings are linked to ENGNW in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Loading ticker…

ENGNW monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	ENGNW Jan avg: 0.28% median: -4.71% win: 33% σ: 10.78% n: 3 2023-11-02 → 2026-07-31	ENGNW Feb avg: 108.30% median: 14.54% win: 67% σ: 196.91% n: 3 2023-11-02 → 2026-07-31	ENGNW Mar avg: 3.81% median: -16.61% win: 33% σ: 38.06% n: 3 2023-11-02 → 2026-07-31	ENGNW Apr avg: -2.16% median: -20.95% win: 33% σ: 33.55% n: 3 2023-11-02 → 2026-07-31	ENGNW May avg: -42.48% median: -39.51% win: 0% σ: 41.61% n: 3 2023-11-02 → 2026-07-31	ENGNW Jun avg: -16.31% median: 0.00% win: 67% σ: 30.44% n: 3 2023-11-02 → 2026-07-31	ENGNW Jul avg: 8.13% median: 10.98% win: 67% σ: 7.18% n: 3 2023-11-02 → 2026-07-31	ENGNW Aug avg: -21.90% median: -21.90% win: 0% σ: 4.78% n: 2 2023-11-02 → 2026-07-31 (current)	ENGNW Sep avg: 47.66% median: 47.66% win: 100% σ: 61.16% n: 2 2023-11-02 → 2026-07-31	ENGNW Oct avg: 78.00% median: 78.00% win: 50% σ: 144.65% n: 2 2023-11-02 → 2026-07-31	ENGNW Nov avg: -2.38% median: -10.69% win: 33% σ: 37.48% n: 3 2023-11-02 → 2026-07-31	ENGNW Dec avg: -0.83% median: 7.35% win: 67% σ: 36.39% n: 3 2023-11-02 → 2026-07-31

ENGNW monthly seasonality strip

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

ENGNW Jan avg: 0.28% median: -4.71% win: 33% σ: 10.78% n: 3 2023-11-02 → 2026-07-31

ENGNW Feb avg: 108.30% median: 14.54% win: 67% σ: 196.91% n: 3 2023-11-02 → 2026-07-31

ENGNW Mar avg: 3.81% median: -16.61% win: 33% σ: 38.06% n: 3 2023-11-02 → 2026-07-31

ENGNW Apr avg: -2.16% median: -20.95% win: 33% σ: 33.55% n: 3 2023-11-02 → 2026-07-31

ENGNW May avg: -42.48% median: -39.51% win: 0% σ: 41.61% n: 3 2023-11-02 → 2026-07-31

ENGNW Jun avg: -16.31% median: 0.00% win: 67% σ: 30.44% n: 3 2023-11-02 → 2026-07-31

ENGNW Jul avg: 8.13% median: 10.98% win: 67% σ: 7.18% n: 3 2023-11-02 → 2026-07-31

ENGNW Aug avg: -21.90% median: -21.90% win: 0% σ: 4.78% n: 2 2023-11-02 → 2026-07-31 (current)

ENGNW Sep avg: 47.66% median: 47.66% win: 100% σ: 61.16% n: 2 2023-11-02 → 2026-07-31

ENGNW Oct avg: 78.00% median: 78.00% win: 50% σ: 144.65% n: 2 2023-11-02 → 2026-07-31

ENGNW Nov avg: -2.38% median: -10.69% win: 33% σ: 37.48% n: 3 2023-11-02 → 2026-07-31

ENGNW Dec avg: -0.83% median: 7.35% win: 67% σ: 36.39% n: 3 2023-11-02 → 2026-07-31

enGene Therapeutics Inc. Warrants (ENGNW) — Stance & relative strength

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Is the crowd watching?

Company snapshot

Frequently asked questions

enGene Therapeutics Inc. Warrants (ENGNW) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Is the crowd watching?

Company snapshot

Frequently asked questions

§ Seasonality

enGene Therapeutics Inc. Warrants (ENGNW) — Stance & relative strength

ENGNW is not confirmed as a leader. 3m RS is unavailable, Market Stance is 47.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Is the crowd watching?

Company snapshot

Frequently asked questions

enGene Therapeutics Inc. Warrants (ENGNW) — Stance & relative strength

ENGNW is not confirmed as a leader. 3m RS is unavailable, Market Stance is 47.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Is the crowd watching?

Company snapshot

Frequently asked questions